Although there can be substantial spontaneous improvements in functional st
atus after a spinal cord injury. therapeutic intervention is desirable in m
any patients to improve the degree of recovery. At present only decompressi
ve surgery and the neuroprotective drug methylprednisolone sodium succinate
are effective and in widespread clinical use. There are limitations to the
efficacy of these therapies in some clinical cases and they cannot restore
satisfactory functional status to all patients. Many drugs have been inves
tigated experimentally to assess their potential to preserve injured tissue
and promote functional recovery in clinically relevant settings, and sever
al of them would be suitable for assessment in future veterinary clinical t
rials. In addition, experimental techniques designed to mould the response
of the CNS to injury, by the promotion of axonal regeneration across the le
sion and the encouragement of local sprouting of undamaged axons, have rece
ntly been successful, suggesting that effective therapy for even very sever
e spinal cord injury may soon be available.